Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
Tichý M, Maisnar V, Palicka V, Friedecký B, Vávrová J, Novotná H, Cermáková Z, Dastych M, Cechák P, Vogtová D, Jarolímková E, Benáková H, Hachová L, Bezdícková D, Kouril F, Zábranská EA, Zenková J, Slabý P, Scudla V, Gregora E, Spicka I, Straub J, Schützova M, Hájek R. Tichý M, et al. Among authors: gregora e. Neoplasma. 2006;53(6):492-4. Neoplasma. 2006. PMID: 17167717
[Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma].
Adam Z, Bednarík J, Neubauer J, Chaloupka R, Fojtík Z, Vanícek J, Pour L, Cermákova Z, Scudla V, Maisnar V, Straub J, Schützová M, Gregora E, Weinreb M, Stuchlíková K, Stanícek J, Hájek R, Krejcí M, Vorlícek J; Czech Myeloma Society. Adam Z, et al. Among authors: gregora e. Vnitr Lek. 2006 Nov;52 Suppl 2:9, 11-31. Vnitr Lek. 2006. PMID: 18175427 Czech.
Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.
Nemec P, Zemanova Z, Greslikova H, Michalova K, Filkova H, Tajtlova J, Kralova D, Kupska R, Smetana J, Krejci M, Pour L, Zahradova L, Sandecka V, Adam Z, Buchler T, Spicka I, Gregora E, Kuglik P, Hajek R. Nemec P, et al. Among authors: gregora e. Biol Blood Marrow Transplant. 2010 Apr;16(4):548-54. doi: 10.1016/j.bbmt.2009.11.025. Epub 2010 Jan 18. Biol Blood Marrow Transplant. 2010. PMID: 20005965 Free article. Clinical Trial.
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma.
Kessler P, Pour L, Gregora E, Zemanova M, Penka M, Brejcha M, Adam Z, Bacovsky J, Fenclova M, Frankova H, Hausdorf P, Walterova L, Heinzova V, Holikova M, Krejci M, Kubackova K, Langrova E, Maisnar V, Meluzinova I, Stavarova Y, Straub J, Scudla V, Gumulec J, Ullrychova J, Hajek R; Czech Myeloma Group. Kessler P, et al. Among authors: gregora e. Klin Onkol. 2011;24(4):281-6. Klin Onkol. 2011. PMID: 21905619
Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
Nemec P, Zemanova Z, Kuglik P, Michalova K, Tajtlova J, Kaisarova P, Oltova A, Filkova H, Holzerova M, Balcarkova J, Jarosova M, Rabasova J, Hruba M, Spicka I, Gregora E, Adam Z, Scudla V, Maisnar V, Schutzova M, Hajek R; Czech Myeloma Group. Nemec P, et al. Among authors: gregora e. Leuk Lymphoma. 2012 May;53(5):920-7. doi: 10.3109/10428194.2011.634042. Epub 2011 Dec 13. Leuk Lymphoma. 2012. PMID: 22023516 Clinical Trial.
10 years of experience with thalidomide in multiple myeloma patients: report of the Czech Myeloma Group.
Minarik J, Sandecka V, Maisnar V, Gregora E, Spicka I, Starostka D, Plonkova H, Jarkovsky J, Walterova L, Wrobel M, Adamova D, Pika T, Melicharova H, Pour L, Radocha J, Pavlicek P, Straub J, Gumulec J, Bacovsky J, Adam Z, Scudla V, Hajek R. Minarik J, et al. Among authors: gregora e. Leuk Res. 2013 Sep;37(9):1063-9. doi: 10.1016/j.leukres.2013.06.019. Epub 2013 Jul 8. Leuk Res. 2013. PMID: 23845888
42 results